Site Search

... Cancer Action Network (ACS CAN) applauds members of the Health & Insurance committee for passing House Bill 1110, Health-care Coverage for Biomarker Testing , this week. The bi-partisan bill, co-sponsored by Rep. Dafna Michaelson Jenet (D) and Rep. Anthony Hartsook (R), aims to expand access to biomarker testing in Colorado.  Biomarker testing has become a game-changing part of cancer care in recent years as it’s a necessary first step ...

This afternoon, the Pennsylvania State House passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. Biomarker testing has revolutionized cancer treatment over the last few decades and is increasingly important in the treatment of other conditions, ...

... House Bill 73 as the 2023 legislative session ended. With the signature of Governor Michelle Lujan Grisham, the bill will expand access to biomarker testing statewide, helping to revolutionize cancer care in New Mexico.  In 2023, more than 11,000 New Mexicans are projected to be diagnosed with ... Governor doesn’t sign this bill into law, existing disparities in cancer outcomes by race, ethnicity, income, and geography could increase. Biomarker testing has become a game-changing part of cancer care in recent years as it’s a necessary first step in opening the door to targeted ...

JACKSON, Miss. –  The Mississippi Senate passed “Jill’s Law” House Bill 565 Wednesday, paving the way for increased access to biomarker testing for Mississippians with state-regulated health insurance plans. Biomarker testing is a key tool used by physicians to identify the most effective treatments for cancer and other diseases. Jill’s Law ensures ...